Mach7 Technologies (ASX:M7T) - Share price, News & Analysis

M7T fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	4/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

M7T Stock Overview

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises worldwide.

Rewards

Trading at 26% below our estimate of its fair value

Earnings are forecast to grow 48.31% per year

Earnings have grown 31.2% per year over the past 5 years

Risk Analysis

No risks detected for M7T from our risk checks.

Mach7 Technologies Competitors

Alcidion Group

ASX:ALC

AU$183.9m

Volpara Health Technologies

ASX:VHT

AU$191.5m

Oneview Healthcare

ASX:ONE

AU$116.1m

Cogstate

ASX:CGS

AU$294.7m

Price History & Performance

Summary of all time highs, changes and price drops for Mach7 Technologies
Historical stock prices
Current Share Price	AU$0.59
52 Week High	AU$1.10
52 Week Low	AU$0.51
Beta	1.32
1 Month Change	-8.46%
3 Month Change	-22.22%
1 Year Change	-44.65%
3 Year Change	70.00%
5 Year Change	240.00%
Change since IPO	-5.56%

Recent News & Updates

May 19

Is Mach7 Technologies Limited (ASX:M7T) Potentially Undervalued?

While Mach7 Technologies Limited ( ASX:M7T ) might not be the most widely known stock at the moment, it saw a...

Shareholder Returns

	M7T	AU Healthcare Services	AU Market
7D	-4.0%	-1.6%	-1.3%
1Y	-44.7%	-22.8%	-2.0%

Return vs Industry: M7T underperformed the Australian Healthcare Services industry which returned -22.8% over the past year.

Return vs Market: M7T underperformed the Australian Market which returned -2% over the past year.

Price Volatility

Is M7T's price volatile compared to industry and market?
M7T volatility
M7T Average Weekly Movement	7.5%
Healthcare Services Industry Average Movement	9.7%
Market Average Movement	9.3%
10% most volatile stocks in AU Market	16.3%
10% least volatile stocks in AU Market	4.1%

Stable Share Price: M7T is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: M7T's weekly volatility (8%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2007	n/a	Mike Lampron	https://www.mach7t.com

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises worldwide. It operates through two segments, Sale of Software Licenses and Rendering of Professional Services. The Company offers enterprise diagnostic viewing solutions that include eUnity Enterprise Viewer and eUnity Diagnostic Viewer.

Mach7 Technologies Fundamentals Summary

How do Mach7 Technologies's earnings and revenue compare to its market cap?
M7T fundamental statistics
Market Cap	AU$142.10m
Earnings (TTM)	-AU$2.60m
Revenue (TTM)	AU$26.30m

5.4x

P/S Ratio

-54.6x

P/E Ratio

Is M7T overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
M7T income statement (TTM)
Revenue	AU$26.30m
Cost of Revenue	AU$17.76m
Gross Profit	AU$8.53m
Other Expenses	AU$11.13m
Earnings	-AU$2.60m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	-0.011
Gross Margin	32.45%
Net Profit Margin	-9.90%
Debt/Equity Ratio	0%

How did M7T perform over the long term?

See historical performance and comparison

New valuation analysis is now available for all ASX stocks. This is in beta.

Future Growth

How is Mach7 Technologies forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

4/6

Future Growth Score 4/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

48.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: M7T is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.8%).

Earnings vs Market: M7T is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: M7T's is expected to become profitable in the next 3 years.

Revenue vs Market: M7T's revenue (10.6% per year) is forecast to grow faster than the Australian market (5.1% per year).

High Growth Revenue: M7T's revenue (10.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: M7T is forecast to be unprofitable in 3 years.

Past Performance

How has Mach7 Technologies performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

31.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: M7T is currently unprofitable.

Growing Profit Margin: M7T is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: M7T is unprofitable, but has reduced losses over the past 5 years at a rate of 31.2% per year.

Accelerating Growth: Unable to compare M7T's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: M7T is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (10.6%).

Return on Equity

High ROE: M7T has a negative Return on Equity (-4.37%), as it is currently unprofitable.

Financial Health

How is Mach7 Technologies's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Stable Cash Runway
Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: M7T's short term assets (A$29.8M) exceed its short term liabilities (A$8.3M).

Long Term Liabilities: M7T's short term assets (A$29.8M) exceed its long term liabilities (A$10.5M).

Debt to Equity History and Analysis

Debt Level: M7T is debt free.

Reducing Debt: M7T has no debt compared to 5 years ago when its debt to equity ratio was 0.2%.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable M7T has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: M7T is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 53.1% per year.

Dividend

What is Mach7 Technologies's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate M7T's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate M7T's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if M7T's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if M7T's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as M7T has not reported any payouts.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

0.6yrs

Average management tenure

CEO

Mike Lampron

3.17yrs

Tenure

AU$633,318

Compensation

Mr. Michael Lampron, also known as Mike, serves as Managing Director and Director of Mach7 Technologies Limited since June 24, 2019 and also serves as Chief Executive Officer. With over 20 years ofexperie...

CEO Compensation Analysis

Compensation vs Market: Mike's total compensation ($USD453.05K) is above average for companies of similar size in the Australian market ($USD288.48K).

Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.

Leadership Team

Experienced Management: M7T's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.

Board Members

Experienced Board: M7T's board of directors are considered experienced (3.3 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: M7T insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/28 00:00
End of Day Share Price	2022/05/27 00:00
Earnings	2021/12/31
Annual Earnings	2021/06/30